News and Events

ACCELEREX woundcare product for approval in Taiwan!

The Accelerex woundcare product is the brand for approval in Taiwan and Asia.  Accelerex is a woundcare product for chronic and hard to heal wounds that utilizes one of The Woundcare Co.,'s broadly-enabling therapuetic technologies... a synthetic composition of polyhydrated ionohens known as “PHI™.” 

Accelerex will be provided to Taiwan/Asia in: 


  • Patches (3 sizes)


  • Tubes (16g)


  • Patches (3 sizes) with honey


  • Tubes (16g) with honey



Announcing The Woundcare Co., Appointment

How do we compete? By offering the most effective technology on the market and by having consistently pleasant and professional service available in all areas worldwide.  Our management philosophy is simple . . . we provide our customers with the products they need and a level of quality service that exceeds their expectations. We select associates for their ability to live up to this promise. That's why we selected Mr. Allan Lan as our company representative for Asia, Africa, and the Middle East. 


The Woundcare Co.,
 ( former Greystone Pharmaceuticals Inc. )

sole Agent In Asia &Asian Regional Office Taipei
Chyuanchya Bio-Tech Co.
Mr. Allan Lan
Director International Sales and Distribution

Asia Office

12F.,No.38,Fuxing N.Rd.,

Zhongshan Dist., Taipei City,10488.Taiwan, R.O.C.

TEL:+886 2 2752 9956
FAX:+886 2 2752 2166


Press Releases

Radien Skin Care Products Press Conference in Taipei, Taiwan.

Accelerex Wound Dressing Press Conference in Taipei.Taiwan.

Head Quarter of The WoundCare Co. and Chyuan Chya Bio had entered new sole Asia agent agreement on July 31, 2015 to support and sustain the outstanding sole Asia agent authrization letter at the same time. 

July 31, 2015

The Woundcare Co., Announces Appointment of Chief Medical Director

April 28, 2007


Fort Myers, FL – Dermagenics U.S., Inc., a subsidiary of The Woundcare Co.  Click here for full press release.


The Woundcare Co., and 3M Health Care announce supply and distribution agreement

3M to distribute product made by Greystone in the U.K. April 19, 2007


Fort Myers, Florida – The Woundcare Co., of Fort Myers, Florida, announced today that it has signed an agreement with 3M Health Care Limited of Loughborough, England for the supply and distribution of The Woundcare Co.,’s advanced wound care dressing, DerMax®, in the United Kingdom. Under the agreement, 3M Health Care Limited will brand and distribute DerMax in the U.K. Greystone's European wound care products subsidiary, Dermagenics Europe, BV, will manufacture the product for 3M. Click here for full press release.


New wound care technology debuted at international conference Ostomy Wound Management

January 26, 2007


The WoundCare CO.,(Memphis, Tenn.), through its European subsidiary Dermagenics BV, announced the U.K. launch of its chronic wound technology — Epi-Max EU®.


Epi-Max EU® is noted for use as a wound dressing to manage diabetic ulcers, decubitus ulcers, leg ulcers, and acute severe wounds where fast epithelialization is required. This is the first wound care product permitted to claim the ability to downregulate matrix metalloproteinase production (MMP). Studies demonstrate this downregulation enhances chronic and acute severe wound healing.


The product is currently marketed and sold under the DerMax® name throughout Europe and the Middle East. Encouraged by the success of DerMax® throughout the continent, Dermagenics looks forward to presenting this state-of-the-art technology globally to provide the healthcare community with wound care alternatives that are effective in accelerating the wound healing process.


Epi-Max EU® made its United Kingdom debut at the Wounds U.K. International Conference held in Harrogate on November 13-15, 2006. The product, which has been approved for the Drug Tariff List, is now available for distribution.


Tennessee Medicare Health Support Program offers monitoring technologies, transportation services to participants

April 11, 2006


XLHealth, one of the nation's fastest-growing disease management companies, and The Woundcare Co., an expert in the development of advanced patient monitoring technologies, have joined forces to facilitate access to health support services for participants in Tennessee's new Medicare Health Support program. Through this partnership, participants in the Medicare Health Support program, which is sponsored by the Centers for Medicare & Medicaid Services and operated in Tennessee by XLHealth, will be offered transportation services and state-of-the-art home health testing equipment as necessary. Click here for the full press release.


The Woundcare Co., to expand into Lee County, Florida

March 14, 2006


Greystone Pharmaceuticals, Inc., a biotech development company specializing in medical devices and pharmaceutical products, has announced its decision to open a corporate headquarters for their holding company in Lee County, Florida. Click here for the full press release.


Dr. Moore wins award for research

September 9, 2005


Dr. Bob Moore was awarded the Health Care Innovations Award by the Memphis Business Journal for his hemostatic and hemorrhagic shock research. Click here for the University of Tennessee's press release.